» Articles » PMID: 16045796

Is Neutrophil Elastase the Missing Link Between Emphysema and Fibrosis? Evidence from Two Mouse Models

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2005 Jul 28
PMID 16045796
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The separation of emphysema from fibrosis is not as clear-cut as it was thought in early studies. These two pathologies may be present at the same time in human lungs and in mice either instilled with elastolytic enzymes or bleomycin or exposed to cigarette-smoke. According to a current view, emphysema originates from a protease/antiprotease imbalance, and a role for antiproteases has also been suggested in the modulation of the fibrotic process. In this study we investigate in experimental animal models of emphysema and fibrosis whether neutrophil elastase may constitute a pathogenic link between these two pathologies.

Methods: This study was done in two animal models in which emphysema and fibrosis were induced either by bleomycin (BLM) or by chronic exposure to cigarette-smoke. In order to assess the protease-dependence of the BLM-induced lesion, a group mice was treated with 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride, a serine proteinase inhibitor active toward neutrophil elastase. Lungs from each experimental group were used for the immunohistochemical assessment of transforming growth factor-beta (TGF-beta) and transforming growth factor-alpha (TGF-alpha) and for determination of the mean linear intercept as well as the percent volume densities of fibrosis and of emphysematous changes. Additionally, the lungs were also assessed for desmosine content and for the determination of elastase levels in the pulmonary interstitium by means of immunoelectron microscopy.

Results: We demonstrate that in BLM-treated mice (i) the development of elastolytic emphysema precedes that of fibrosis; (ii) significant amount of elastase in alveolar interstitium is associated with an increased expression of TGF-beta and TGF-alpha; and finally, (iii) emphysematous and fibrotic lesions can be significantly attenuated by using a protease inhibitor active against neutrophil elastase. Also, in a strain of mice that develop both emphysema and fibrosis after chronic cigarette-smoke exposure, the presence of elastase in alveolar structures is associated with a positive immunohistochemical reaction for reaction for both TGF-beta and TGF-alpha.

Conclusion: The results of the present study strongly suggest that neutrophil elastase may represent a common pathogenic link between emphysema and fibrosis. Proteases and in particular neutrophil elastase could act as regulatory factors in the generation of soluble cytokines with mitogenic activity for mesenchymal cells resulting either in emphysema or in fibrosis or both.

Citing Articles

Immunohistochemical Study of Airways Fibrous Remodeling in Smoking Mice.

Balzano E, De Cunto G, Goracci C, Bartalesi B, Cavarra E, Lungarella G J Histochem Cytochem. 2023; 71(11):577-599.

PMID: 37818941 PMC: 10617442. DOI: 10.1369/00221554231204926.


Proteolysis and Deficiency of α1-Proteinase Inhibitor in SARS-CoV-2 Infection.

Akbasheva O, Spirina L, Dyakov D, Masunova N Biochem Mosc Suppl B Biomed Chem. 2022; 16(4):271-291.

PMID: 36407837 PMC: 9668222. DOI: 10.1134/S1990750822040035.


Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.

Sangani R, Andrew Ghio , Culp S, Patel Z, Sharma S Int J Chron Obstruct Pulmon Dis. 2021; 16:1873-1885.

PMID: 34188464 PMC: 8232869. DOI: 10.2147/COPD.S307192.


Innate Immunity and Cell Surface Receptors in the Pathogenesis of COPD: Insights from Mouse Smoking Models.

De Cunto G, Cavarra E, Bartalesi B, Lucattelli M, Lungarella G Int J Chron Obstruct Pulmon Dis. 2020; 15:1143-1154.

PMID: 32547002 PMC: 7246326. DOI: 10.2147/COPD.S246219.


Functional contribution of sphingosine-1-phosphate to airway pathology in cigarette smoke-exposed mice.

De Cunto G, Brancaleone V, Riemma M, Cerqua I, Vellecco V, Spaziano G Br J Pharmacol. 2019; 177(2):267-281.

PMID: 31499592 PMC: 6989954. DOI: 10.1111/bph.14861.


References
1.
Selman M, King T, Pardo A . Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001; 134(2):136-51. DOI: 10.7326/0003-4819-134-2-200101160-00015. View

2.
Cavarra E, Martorana P, Bartalesi B, Fineschi S, Gambelli F, Lucattelli M . Genetic deficiency of alpha1-PI in mice influences lung responses to bleomycin. Eur Respir J. 2001; 17(3):474-80. DOI: 10.1183/09031936.01.17304740. View

3.
Dunsmore S, Roes J, Chua F, Segal A, Mutsaers S, Laurent G . Evidence that neutrophil elastase-deficient mice are resistant to bleomycin-induced fibrosis. Chest. 2001; 120(1 Suppl):35S-36S. DOI: 10.1378/chest.120.1_suppl.s35. View

4.
Cavarra E, Bartalesi B, Lucattelli M, Fineschi S, Lunghi B, Gambelli F . Effects of cigarette smoke in mice with different levels of alpha(1)-proteinase inhibitor and sensitivity to oxidants. Am J Respir Crit Care Med. 2001; 164(5):886-90. DOI: 10.1164/ajrccm.164.5.2010032. View

5.
. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory.... Am J Respir Crit Care Med. 2002; 165(2):277-304. DOI: 10.1164/ajrccm.165.2.ats01. View